Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): Vesiculation and/or proteolysis?

Immunopharmacology

Volumn 38, Issue 1-2, 1997, Pages 129-140

  Dervillez, Xavier ^a   Oudin, Stéphane ^a   Libyh, Marcelle Tonye ^a   Tabary, Thierry ^a   Reveil, Brigitte ^a   Philbert, Frédérique ^a   Bougy, Francine ^a   Pluot, Michel ^a   Cohen, Jacques H M ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Calcium ionophore A23187; Complement receptor type 1 (CR1); Electron microscopy; Erythrocyte; Exocytosis; Flow cytometry

Indexed keywords

CALCIMYCIN; CALCIUM ION; CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C3B RECEPTOR;

ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; ERYTHROCYTE; EXOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MEMBRANE VESICLE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

AGING; ALLELES; CALCIMYCIN; COMPLEMENT C1R; COMPLEMENT C4B; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; ERYTHROCYTES; EXOCYTOSIS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IONOPHORES; MICROSCOPY, ELECTRON; PAPAIN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, COMPLEMENT; RECEPTORS, COMPLEMENT 3B; SYNAPTIC VESICLES;

EID: 0031458625     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00066-0     Document Type: Article

References (56)

1. ++ induced biochemical changes in human erythrocytes and their relation to microvesiculation. Biochem. J. 198, 433.
2. ++]. Nature 261, 58.
3. Bendayan, M., 1984. Protein A gold electron microscopic immunochemistry: Methods, applications and limitations. J. Electron. Microsc. Tech. 1, 243-270.
4. Bonnet, N., Lebonvallet, S., Girod, S., Ploton, D., Boulanger, F., Bonhomme, A., 1990. Semi-automatic quantification of dense markers in cytochemistry. Trans R. Microsc. Soc. Adam Hilger 1, 623-626.
5. Bütikofer, P., Kuypers, F.A., Xu, C.M., Chiu, D.T.Y., Lubin, B., 1989. Enrichment of two glycosyl-phophatidylinositol-anchored proteins, AChE and decay accelerating factor, in vesicles released from human red blood cells. Blood 74 (6), 1481-1485.
6. Coakley, W.T., Bater, A.J., Deeley, J.O.T., 1978. Vesicle production on heated and stressed erythrocytes. Biochem. Biophys. Acta 512, 318.
7. Cohen, J.H., Aubry, J.P., Jouvin, M.H., Wijdenes, J., Banchereau, J., Kazatchkine, M.D., Revillard, J.P., 1987. Enumeration of CR1 Complement receptors on erythrocytes using a new method for detecting low density cell surface antigens by flow cytometry. J. Immunol. Methods 99 (1), 53-58.
8. Cohen, J.H., Autran, B., Jouvin, M.H., Aubry, J.P., Rozembaum, W., Banchereau, J., Debre, P., Revillard, J.P., Kazatchkine, M.D., 1988. Decrease of erythrocyte receptors for the C3b fragment of Complement in acquired immunodeficiency syndrome. Presse Med. 17 (15), 727-730.
9. Cohen, J.H., Caudwell, V., Levi-Strauss, M., Bourgeois, P., Kazatchkine, M.D., 1989a. Genetic analysis of CR1 expression on erythrocytes of patients with systemic lupus erythematosus. Arthritis Rheum. 32 (4), 393-397.
10. Cohen, J.H., Geffriaud, C., Caudwell, V., Kazatchkine, M.D., 1989b. Genetic analysis of CR1 (the C3b Complement receptor, CD35) expression on erythrocytes of HIV-infected individuals. AIDS 3 (6), 397-399.
11. Cohen, J.H., Lutz, H.U., Pennaforte, J.L., Bouchard, A., Kazatchkine, M.D., 1992. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 87 (3), 422-428.
12. Cook, J.M., Kazatchkine, M.D., Bourgeois, P., Mignon, F., Mery, P., Kahn, M.F., 1986. Anti-C3b receptor (CR1) antibodies in patient with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 38, 135.
13. Cornacoff, J.B., Hebert, L.A., Smead, W.L., Van Aman, M.E., Birmingham, D.J., Waxman, F.J., 1983. Primate erythrocyte immune complex clearing mechanism. J. Clin. Invest. 71, 236-247.
14. Cornillet, P., Philbert, F., Kazatchkine, M.D., Cohen, J.H., 1991. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and HindIII restriction enzyme digestion. J. Immunol. Methods 136 (2), 193-197.
15. Davies, K.A., Savill, J., Walport, M.J., 1989. In vitro transfer of immune complex from erythrocytes to monocytes and macrophages. Complement Inflam. 6, 382.
16. Davies, K.A., Hird, V., Stewart, S., Sivolapenko, G.B., Jose, P., Epenetos, A.A., Walport, M.J., 1990. A study of in-vivo immune complex formation and clearance in man. J. Immunol. 144, 4613-4620.
17. Dumaswala, U.J., Greenwalt, T.J., 1984. Human erythrocytes shed exocytic vesicles in vivo. Transfusion 24, 490.
18. Dykman, T.R., Cole, J.L., Iida, K., Atkinson, J.P., 1983. Polymorphism of the human erythrocyte C3b/C4b receptor. Proc. Natl. Acad. Sci. USA 80, 1698-1702.
19. Dykman, T.R., Hatch, J.A., Aqua, M.S., Atkinson, J.P., 1985. Polymorphism of the C3b/C4b receptor: Identification of a rare variant. J. Immunol. 134, 1787-1789.
20. Fearon, D.T., 1979. Regulation of the amplification C3 convertase of human Complement by an inhibitory protein isolated from human erythrocyte membrane. Proc. Natl. Acad. Sci. USA 76, 5867-5871.
21. Fearon, D.T., 1980. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte. polynuclear leucocyte, B lymphocyte and monocyte . J. Exp. Med. 152, 20.
22. Fearon, D.T., Wong, W.W., 1983. Complement ligand-receptor interactions that mediate biological responses. Annu. Rev. Immunol. 1, 243-271.
23. Fearon, D.T., 1984. Cellular receptors for fragments of the third component of Complement. Immunol. Today 5, 105.
24. Hebert, L.A., Cosio, F.G., Birmingham, D.J., Mahan, J.D., 1991. Biologic significance of the erythrocyte Complement receptor: A primate prerequisite. J. Lab. Clin. Med. 118 (4), 301-308.
25. Hebert, L.A., 1991. The clearance of immune complexes from the circulation of man and other primates. Am. J. Kidney Dis. 17 (3), 352-361.
26. Iida, K., Nussenzweig, V., 1981. Complement receptor is an inhibitor of the Complement cascade. J. Exp. Med. 153, 1138.
27. Iida, K., Mornaghi, R., Nussenzweig, V., 1982. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J. Exp. Med. 155, 1427.
28. Iida, K., Whitlow, M.B., Nussenzweig, V., 1991. Membrane vesiculation protects erythrocytes from destruction by Complement. J. Immunol. 147, 2638-2642.
29. Klickstein, L.B., Wong, W.W., Smith, J.A., Weis, J.H., Wilson, J.G., Fearon, D.T., 1987, Human C3b/C4b receptor (CR1): Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristic of C3b/C4b binding proteins. J. Exp. Med. 165, 1095-1112.
30. Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
31. Lutz, H.U., Stammler, P., Fasler, S., Ingold, M., Fehr, J., 1992. Density separation of human red blood cells on self forming Percoll gradients: Correlation with cell age. Biochim. Biophys. Acta 1116, 1.
32. Medof, M.E., Iida, K., Mold, C., Nussenzweig, V., 1982. Unique role of the Complement receptor CR1 in the degradation of C3b associated with immune complexes. J. Exp. Med. 156, 1739.
33. Miyakawa, Y., Amada, A., Kosaka, K., Tsuda, F., Kosugi, E., Mayumi, M., 1981. Defective immune adherence receptor (C3b) on erythrocytes from patients with systemic lupus erythematosus. Lancet 2, 493.
34. Moldenhauer, F., Botto, M., Walport, M.J., 1988. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: No correlation with structural or numerical polymorphisms. Clin. Exp. Immunol. 72, 74-78.
35. Nielsen, C.H. et al., 1997. Erythrocytes from patients with Systemic lupus erythematosus exhibit diminished capacity to inhibit the uptake of Complement-opsonized immune complexes and production of oxygen metabolites by neutrophils (PMN). Exp. Clin. Immunogenet. 14, 76.
36. Paccaud, J.P., Carpentier, J.L., Schifferli, J.A., 1988. Direct evidence for the clustered nature of Complement receptors type 1 in the erythrocytes membranes. J. Immunol. 141, 3889-3894.
37. Pascual, M., Lutz, H.U., Steiger, G., Stammler, P., Schifferli, J.A., 1993. Release of vesicles enriched in Complement receptor 1 from human erythrocytes. J. Immunol. 151 (1), 397-404.
38. Quadri, R.A., Schifferli, J.A., 1992. Over-estimation of the number of Complement receptor type 1 (CR1) on erythrocytes. Scand. J. Immunol. 36, 125-130.
39. Ripoche, J., Sim, R.B., 1986. Loss of Complement receptor type 1 (CR1) on ageing of erythrocytes. Biochem. J. 235, 815-821.
40. Ross, G.D., Medof, M.E., 1985. Membrane Complement receptors specific for bound fragments of C3. Adv. Immunol. 37, 217-267.
41. Ross, G.D., Yount, W.J., Walport, M.J., Winfield, J.B., Parker, C.J., Fuller, C.R., Taylor, R.P., Myones, B.L., Lachmann, P.J., 1985. Disease-associated loss of erythrocyte Complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving auto-antibodies and/or Complement activation. J. Immunol. 135, 2005-2014.
42. Sadallah, S. et al., 1997a. CR1, CD35 in synovial fluid from patient with inflammatory joint diseases. Arthritis Rheum. 40, 520-526.
43. Sadallah, S. et al., 1997b. Proteolytic release of Complement receptor one (CR1) from the erythrocyte surface. Exp. Clin. Immunogenet. 14, 77.
44. Schifferli, J.A., Taylor, R.P., 1989. Physiological and pathological aspects of circulating immune complexes. Kidney Int. 35, 993-1003.
45. ++ dependent exocytotic elimination of C5b-9 pores. Blood 68, 556.
46. Tausk, F.A., McCutchan, J.A., Spechko, P., Schreiber, R.D., Gigli, I., 1986. Altered erythrocyte C3b receptor expression, immune complexes and Complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J. Clin. Invest. 78, 977.
47. Test, S.T., Butikofer, P., Yee, M.C., Kuypers, F.A., Lubin, B., 1991. Characterization of the Complement sensitivity of calcium loaded human erythrocytes. Blood 78, 3056.
48. Walport, M.J., Ross, G.D., Mackworth-Young, C., Watson, J.V., Hogg, N., Lachmann, P.J., 1985. Family studies of erythrocyte Complement receptor type 1 levels: Reduced levels in patients with systemic lupus erythematosus are acquired: Not inherited. Clin. Exp. Immunol. 59, 547-554.
49. Walport, M.J., Ng, Y.C., Lachmann, P.J., 1987. Erythrocytes transfused into patients with systemic lupus erythematosus and haemolytic anemia lose Complement receptor type 1 from their cell surface. Clin. Exp. Immunol. 69, 501-507.
50. Wilson, J.G., Wong, W.W., Schur, P.H., Fearon, D.T., 1982. Mode of inheritance of decreased C3b receptor activity on erythrocytes from patients with systemic lupus erythematosus. N. Engl. J. Med. 307, 981-986.
51. Wilson, J.G., Jack, R.M., Wong, W.W., Schur, P.H., Fearon, D.T., 1985. Autoantibody to the C3b/C4b receptor and absence of this receptor from erythrocytes of a patient with systemic lupus erythematosus. J. Clin. Invest. 76, 182-190.
52. Wilson, J.G., Murphy, E.E., Wong, W.W., Klickstein, L.B., Weis, J.H., Fearon, D.T., 1986. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J. Exp. Med. 164, 50-59.
53. Wong, W.W., Wilson, J.G., Fearon, D.T., 1983. Genetic regulation of a structural polymorphism of the human C3b receptor. J. Clin. Invest. 72, 685-693.
54. Wong, W.W., Cahill, J.M., Rosen, M.D., Kennedy, C.A., Bonaccio, E.T., Morris, M.J., Wilson, J.G., Klickstein, L.B., Fearon, D.T., 1989. Structure of the human CR1 gene: Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele. J. Exp. Med. 169, 847-863.
55. Wong, W.W., 1990. Structural and functional correlation of the human Complement receptor type 1. J. Invest. Derm. 94 (6), 64S-67S.
56. Yoon, S.H., Fearon, D.T., 1985. Characteristics of a soluble form of the C3b/C4b receptor (CR1) in human plasma. J. Immunol. 134, 3332-3338.